South Africa TB Drug
![South Africa TB Drug](/upload/8347471/9f46c250dfa24ee2bee93fc575246729--0--aed318d3f2ae450795e9d04af2f78da4.jpg?w=1000&original=)
South Africa TB Drug
FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on February 8, 2024. South African authorities have dropped an investigation into Johnson & Johnson for alleged anti-competitive practices after the company agreed not to enforce its patent on a critical TB medication, a move that should allow generic producers to make the drug at much lower prices. (AP Photo/Ted Shaffrey)
Абонирайте се
Влезте във Вашата БТА
![South Africa TB Drug](/upload/8350590/ba492067b2854338985a4a52a1eee8a2--0--e29cec342c4545a1811b9f96b4419c13.jpg?w=1000&original=)
South Africa TB Drug
FILE - A TB (tuberculosis) patient after being administered medication at a clinic in Durban, South Africa on Oct. 17, 2005. Medical advocacy groups have welcomed Johnson & Johnson's decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices. The move comes after South African authorities opened an investigation into the conglomerate. (AP Photo/Themba Hadebe/File)
Абонирайте се
Влезте във Вашата БТА
![South Africa TB Drug](/upload/8350614/28bb1621478a4ae9852956c77eb559bc--0--bd783251296b415cb985e8761fa786b5.jpg?w=1000&original=)
South Africa TB Drug
FILE — Nivard Langa, awaits his turn to take tuberculosis (TB) medication at a clinic in Durban, South Africa, on Oct. 17, 2005. Medical advocacy groups have welcomed Johnson & Johnson's decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices. The move comes after South African authorities opened an investigation into the conglomerate. (AP Photo/Themba Hadebe/File)
Абонирайте се
Влезте във Вашата БТА
Избиране на снимки
Моля потвърдете избраните снимки. Това действие не е свързано с плащане. Ако продължите, избраните снимки ще бъдат извадени от баланса на вашите активни абонаментни пакети.
Изтегляне на снимка
Моля потвърдете изтеглянето на снимката/ите
![South Africa TB Drug](/upload/8347471/9f46c250dfa24ee2bee93fc575246729--0--aed318d3f2ae450795e9d04af2f78da4.jpg?w=270&h=180)
![South Africa TB Drug](/upload/8350590/ba492067b2854338985a4a52a1eee8a2--0--e29cec342c4545a1811b9f96b4419c13.jpg?w=270&h=180)
![South Africa TB Drug](/upload/8350614/28bb1621478a4ae9852956c77eb559bc--0--bd783251296b415cb985e8761fa786b5.jpg?w=270&h=180)
FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on February 8, 2024. South African authorities have dropped an investigation into Johnson & Johnson for alleged anti-competitive practices after the company agreed not to enforce its patent on a critical TB medication, a move that should allow generic producers to make the drug at much lower prices. (AP Photo/Ted Shaffrey)